Year in Review: Coalition highlights from 2020

Year in Review: Coalition highlights from 2020

Year in review
The Coalition for Global Hepatitis Elimination

The COVID-19 pandemic disrupted all aspects of society, including efforts to combat viral hepatitis. Nonetheless, the Coalition remained committed to supporting the work of hepatitis elimination programs either by providing resources to inform the continuation of hepatitis services under changing conditions or by spearheading initiatives to keep hepatitis elimination on national and global health agenda. With your partnership, below are the some of the Coalition’s highlights from 2020.

January

February

March

  • Coalition authors presented two abstracts on global and regional HBV and HCV mortality at the Asia Pacific Association for the Study of the Liver (APASL) conference in Bali, Indonesia in March 2019Coalition partners provided a tour of  Bali Peduli, a clinic in Indonesia making HBV/HCV care accessible to vulnerable populations
  • In response to the emerging COVID-19 pandemic,  a synthesis of the relationship between SARS-CoV-2 infection and   liver disease was developed and added to the Coalition  evidence base.

April

  • The results of the systematic c review of global, regional, national, and sub-national action plans on hepatitis B and C control and elimination were made available on the Coalition website.
  • Winners of the first annual Hepatitis Elimination Video Contest were announced with the Grand Prize going to the  “Connecting with Care Ahtahkakoop” by the International Network on Hepatitis in Substance Users (INHSU), Saskatchewan Canada.

May

June

  • Data dashboards for 190+ countries were updated and expanded. Additional functionalities on the dashboards allow users to view a wider range of epidemiological, program monitoring, and policy indicators, to view the source of all data, and to download all data tables and graphs.
  • US-based public health organizations joined with the Coalition to call for U.S. support of the World Health Organization.
  • The Coalition coordinated the production of a video to highlight the partnerships making HCV testing and treatment in drug treatment centers a reality in the state of Georgia, United States.

July

August

  • A  global survey of providers to understand the impact of COVID on hepatitis prevention, care and treatment was released.

September

October

  • To honor the Nobel Prize, the Coalition published a call to action in the Lancet  for the philanthropic community to mobilize the resources needed for hepatitis elimination.
  • The Coalition participated in the WHO Strategic and Technical Advisory Committee on HIV and Viral Hepatitis (STAC-HIVHEP) and STI Partners 28-30 October 2020.
  • The Coalition hosted the third author interview in the Clinical Liver Disease, “Innovations in Hepatitis Elimination”. This month’s article was “Working Toward Elimination of Hepatitis C: The Kentucky Hepatitis Academic Mentorship Program.” For the interview, Dr. Ward spoke with Dr. Cave of the University of Louisville and Dr. Judith Feinberg of the University of West Virginia.
  • In an AASLD webinar, the Coalition presented the impact of the COVID-19 response on hepatitis elimination  

November

  • The Coalition provided five presentations for the AASLD Liver Meeting regarding the global burden of disease 2019 country-level HBV as well as HCV mortality trends, global and US scale-up of HCV testing, HCV retreatment in resource constrained settings, and study on HCV treatment among PWID and COVID-19 prevention.
  • Coalition provides perspectives on global hepatitis elimination for the  launch of the Japan Hep Elimination Project.
  • Coalition launches  Technical Assistance Help Desk.
  • Coalition participates in WHO Meeting on the Validation of Elimination of Viral Hepatitis as a Public Health Threat

December

  • The second Hep Test webinar, “A Global Tour of Options for Scaling-Up HCV Testing to Reach Elimination Goals,” was convened with presentations on HCV testing from Egypt, Georgia, Mexico, Rwanda, and Vietnam.
  • The Coalition led the organization of the International Viral Hepatitis Elimination Meeting
  • The Coalition participated in the WPRO Expert Review Panel of Hepatitis B Control
  • The Coalition Executive Board and Technical Advisory Board held meetings.

 

Thank you to all our partners for contributing to these successes in 2020. We look forward to working with you in 2020 to continue to make progress towards hepatitis elimination!